Brian Czerniecki, MD, PhD, Ductal Carcinoma In Situ of the Breast (DCIS) Vaccine Trial

November 25, 2010

The Philadelphia Inquirer

Dodt, now 56, of Palm City, Fla., had received Brian J. Czerniecki's experimental vaccine to treat her early-stage breast cancer, called DCIS, before having surgery to remove the cancer. The pathologist who examined the excised tissue under a microscope could not find any malignant cells. Revved by the vaccine, her immune system had wiped out the cancer.

Few other patients have responded so completely to the vaccine, and no one can yet say whether the protective effect will decline over time. Still, in a field littered with failures, Czerniecki's team has found a way to make the concept - a therapeutic cancer vaccine - work well... Read More

For details on Dr. Czerniecki's trial, click here



Brian Czerniecki, MD, PhD, an associate professor of Endocrine and Oncologic Surgery was featured in a CBS 3 news segment spotlighting a breast cancer vaccine trial he is leading. The vaccine, which is made with a patient's own white blood cells, creates an immune response to kill cancer cells. "The initial results from the trial are extremely encouraging," says Czerniecki. The patient featured in the segment was diagnosed with DCIS,  non-invasive form of breast cancer. She reports that at the end of her trial she is now cancer free. Vaccine trials like these for the treatment of cancer pave the way for future vaccines that one day may prevent the disease... Read More

Related Information
This booklet provides information on ductal carcinoma in situ of the breast (DCIS), the different types of DCIS and possible treatment options. It also answers frequently asked questions about DCIS.
  • For more information on this trial, call 1-800-789-PENN (7366)